Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Cost of Revenue (2018 - 2025)

Historic Cost of Revenue for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $30.6 million.

  • Viemed Healthcare's Cost of Revenue rose 2934.88% to $30.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.3 million, marking a year-over-year increase of 2605.11%. This contributed to the annual value of $91.1 million for FY2024, which is 2966.04% up from last year.
  • As of Q3 2025, Viemed Healthcare's Cost of Revenue stood at $30.6 million, which was up 2934.88% from $26.3 million recorded in Q2 2025.
  • Viemed Healthcare's Cost of Revenue's 5-year high stood at $30.6 million during Q3 2025, with a 5-year trough of $9.8 million in Q2 2021.
  • In the last 5 years, Viemed Healthcare's Cost of Revenue had a median value of $17.2 million in 2023 and averaged $18.0 million.
  • As far as peak fluctuations go, Viemed Healthcare's Cost of Revenue tumbled by 4225.79% in 2021, and later surged by 3368.7% in 2024.
  • Viemed Healthcare's Cost of Revenue (Quarter) stood at $12.3 million in 2021, then increased by 18.8% to $14.6 million in 2022, then increased by 27.48% to $18.6 million in 2023, then surged by 31.83% to $24.6 million in 2024, then grew by 24.48% to $30.6 million in 2025.
  • Its last three reported values are $30.6 million in Q3 2025, $26.3 million for Q2 2025, and $25.8 million during Q1 2025.